FIELD: biochemistry, biotechnology. SUBSTANCE: method of isolation and purification of human recombinant tumor necrosis beta-factor involves culturing the strain-producer E. coli SG 20050/pLT21, ultrasonic cell disintegration, removal of cellular debris, chromatography purification on columns with DEAE-cellulose and hydroxyapatite and an additional stage of purification on hydroxyapatite in gradient concentration of potassium dihydrogen phosphate solutions at pH values 7.0-7.2. Method ensures to obtain the preparation of human recombinant tumor necrosis beta-factor free of impurities of foreign proteins, DNA and lipopolysaccharides and useful for medicinal aims. EFFECT: improved method of preparing, enhanced purity. 2 dwg, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF HUMAN RECOMBINANT TUMOR NECROSIS ALPHA-FACTOR PREPARING | 1997 |
|
RU2144958C1 |
METHOD OF RESTRICTION ENDONUCLEASE PRODUCING | 1997 |
|
RU2136749C1 |
METHOD FOR PREPARING HIGHLY PURIFIED RECOMBINANT POLYPEPTIDE WITH PROPERTY OF HUMAN TUMOR NECROSIS FACTOR-ALPHA | 2004 |
|
RU2274656C1 |
MOLECULAR VECTOR FOR DELIVERING GENES TO TARGET CELLS | 2000 |
|
RU2190018C2 |
METHOD OF ENDONUCLEASE RESTRICTION BSE 21 I PREPARING | 1999 |
|
RU2184777C2 |
METHOD FOR PREPARING ANTINEOPLASTIC DRUG AGAINST BONE METASTASES IN FORM OF CONJUGATE OF PROTEIN-CYTOKINE AND AMINOBISPHOSPHONATE | 2016 |
|
RU2631486C1 |
METHOD OF PREPARING POLYPEPTIDE SHOWING HUMAN LYMPHOTOXIN PROPERTY | 1992 |
|
RU2048521C1 |
METHOD FOR PREPARING ENDONUCLEASE RESTRICTION SST 12I | 2001 |
|
RU2233877C2 |
METHOD OF PRODUCING RECOMBINANT BACTERIUM ESCHERICHIA COLI BIOMASS ENRICHED WITH POLYPEPTIDE ELICITING HUMAN LYMPHOTOXIN PROPERTY | 1997 |
|
RU2122580C1 |
METHOD OF PRODUCTION AND PREPARATION OF ANALOGUE OF HUMAN RECOMBINANT INTERFERON GAMMA | 2006 |
|
RU2326944C2 |
Authors
Dates
1999-06-27—Published
1997-04-10—Filed